Drug Topics
FEBRUARY 7, 2025
The American Pharmacists Association announced the launch of its transformative HealthShifts platform in collaboration with the California Pharmacists Association and powered by Locumate.
PharmaVoice
FEBRUARY 7, 2025
While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 7, 2025
Investigators from the University of Rhode Island College of Pharmacy discuss 2 studies that assessed perspectives on pharmacist prescribed hormonal contraceptives.
Pharmacy Times
FEBRUARY 7, 2025
Donna Ryan discusses the landscape of GLP-1 medications and the lineup of indications that the drug class has received indications for in recent years.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 7, 2025
RBI-4000 is a self-replicating RNA (srRNA) vaccine developed to stimulate virus-neutralizing immune responses to rabies for prophylactic use.
Pharmacy Times
FEBRUARY 7, 2025
The designation builds on previous regulatory action for ADI-001 and allows for expedited development of the treatment for systemic lupus erythematosus.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
FEBRUARY 7, 2025
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.
Drug Topics
FEBRUARY 7, 2025
Researchers addressed unmet needs in the treatment of chronic pain for patients living with axial spondyloarthritis.
Fierce Healthcare
FEBRUARY 7, 2025
For virtual-only prescribers of buprenorphine, like Bicycle Health, the future of treatment for patients with opioid use disorder hangs in the balance of a tricky web of final and proposed regulations.
Drug Topics
FEBRUARY 7, 2025
The survey results show 1 in 4 Americans ranked health care access and affordability as their highest public health priority for government officials to address.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
FEBRUARY 7, 2025
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.
STAT
FEBRUARY 7, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning.
Fierce Healthcare
FEBRUARY 7, 2025
Molina Healthcare CEO Joe Zubretsky predicted future Medicaid reform in Congress will be minimal. The insurer missed its quarterly earnings target and previewed its 2025 guidance.
Pharmaceutical Technology
FEBRUARY 7, 2025
Sanofi has agreed to purchase its own shares worth 2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
FEBRUARY 7, 2025
The decision offers patients with antimicrobial resistance, who have limited or no treatment options, a new alternative.
pharmaphorum
FEBRUARY 7, 2025
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.
Pharmaceutical Technology
FEBRUARY 7, 2025
With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK charity behind the popular Dry January initiative, found that 30% of men and 26% of women in the UK wished to reduce the amount of alcohol they drank in 2024.
Pharmacy Times
FEBRUARY 7, 2025
Ming-Hei Tai, PharmD, BCOP, shares his concerns about the AQUILA trial and use of daratumumab for smoldering multiple myeloma.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
FEBRUARY 7, 2025
Two startups that aim to make it easier for consumers to connect with dietitians and nutrition counseling each raised $50 million as demand grows for metabolic health solutions.
Pharmacy Times
FEBRUARY 7, 2025
Africa's unparalleled genetic diversity presents both a challenge and an opportunity to advance precision medicine, with a focus on leveraging pharmacogenetics to improve drug efficacy and reduce adverse reactions.
pharmaphorum
FEBRUARY 7, 2025
Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.
Pharmacy Times
FEBRUARY 7, 2025
Catriona Jamieson, MD, PhD, discusses the role of stress-activated base editors like ADAR1p150 and APOBEC enzymes in cancer progression and highlights innovative approaches to halt these processes and improve therapeutic outcomes.
Pharmaceutical Technology
FEBRUARY 7, 2025
Relmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.
Pharmacy Times
FEBRUARY 7, 2025
More accurate prognostic risk assessment could aid pharmacists in the management and counseling of patients with primary myelofibrosis.
Pharmaceutical Commerce
FEBRUARY 7, 2025
What factors should be consideredand how can both parties benefit long-term?
Pharmacy Times
FEBRUARY 7, 2025
New therapies are being developed for individuals with gout.
The Checkup by Singlecare
FEBRUARY 7, 2025
Mirtazapine is a prescription medication approved to treat depression, and is particularly helpful for improving sleep and overall mood. Though this medication can be effective, some who take it might find themselves at a dinner party, a night out with friends, or another situation that involves alcohol. However, mixing mirtazapine and alcohol is not recommended due to potential health risks and increased side effects, like drowsiness and dizziness.
Pharmaceutical Technology
FEBRUARY 7, 2025
Alumis and Acelyrin have announced a definitive merger agreement, which will result in an all-stock transaction.
Pharmacy Times
FEBRUARY 7, 2025
The quadruple treatment was active and safe as initial therapy for older patients with transplant-ineligible multiple myeloma.
Pharmaceutical Technology
FEBRUARY 7, 2025
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.
Pharmacy Times
FEBRUARY 7, 2025
ABO-101 is supported by preclinical data that demonstrated significant reductions in urinary oxalate in PH1 disease models.
Pharmaceutical Technology
FEBRUARY 7, 2025
AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to benefit.
The Happy PharmD
FEBRUARY 7, 2025
Forget everything you think you know about grocery store pharmacies. Publix is setting a new standard, and it’s not just about filling prescriptions in a corner of the grocery store anymore. Publix Pharmacy is evolving into something much moreoffering healthcare services that some of the larger chains haven’t quite embraced yet. But is working as a pharmacist at Publix the right move for you?
Expert insights. Personalized for you.
341 
Let's personalize your content